Works matching DE "AFLIBERCEPT"

Results: 330

Electrophysiological evaluation and 18-month follow-up of two regimens with aflibercept for neovascular age-related macular degeneration.

Published in:

Documenta Ophthalmologica, 2022, v. 144, n. 2, p. 99, doi. 10.1007/s10633-021-09863-7

By:

Schroeder, Marion;
Kjellström, Ulrika;
Lövestam-Adrian, Monica

Publication type:

Article

A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the Netherlands.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2025, v. 263, n. 2, p. 327, doi. 10.1007/s00417-024-06588-6

By:

Quist, Sara W.;
Nab, Hidde;
Postma, Maarten;
Amarakoon, Sankha;
van Asten, Freekje;
Freriks, Roel

Publication type:

Article

Subconjunctival aflibercept inhibits corneal angiogenesis and VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 12, p. 3881, doi. 10.1007/s00417-024-06560-4

By:

Yoon, Chang Ho;
Ko, Jung Hwa;
Lee, Hyun Ju;
Song, Hyun Beom;
Oh, Joo Youn

Publication type:

Article

Five-year outcomes of treat and extend regimen using intravitreal aflibercept injection for treatment-naïve age-related macular degeneration.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 11, p. 3483, doi. 10.1007/s00417-024-06519-5

By:

Ota, Hikaru;
Kataoka, Keiko;
Asai, Keiko;
Takeuchi, Jun;
Nakano, Yuyako;
Nakamura, Koichi;
Todoroki, Takahito;
Nishiguchi, Koji M

Publication type:

Article

The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 11, p. 3501, doi. 10.1007/s00417-024-06518-6

By:

Maguire, Matthew;
Laidlaw, Dah;
Davies, Nigel;
Hammond, Christopher

Publication type:

Article

Influence of submacular hemorrhage at baseline on the long-term outcomes of aflibercept treatment for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 10, p. 3099, doi. 10.1007/s00417-024-06453-6

By:

Hosokawa, Mio Morizane;
Ouchi, Chihiro;
Shiode, Yusuke;
Kimura, Shuhei;
Matoba, Ryo;
Morita, Tetsuro;
Morizane, Yuki

Publication type:

Article

Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 2-year results from the Japan subgroup of the phase III TENAYA trial.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 8, p. 2439, doi. 10.1007/s00417-024-06377-1

By:

Koizumi, Hideki;
Gomi, Fumi;
Tsujikawa, Akitaka;
Honda, Shigeru;
Mori, Ryusaburo;
Ochi, Haruka;
Iwasaki, Keisuke;
Okada, Annabelle Ayame

Publication type:

Article

Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 6, p. 1755, doi. 10.1007/s00417-024-06373-5

By:

Huang, Yu-Te;
Tien, Peng-Tai;
Chen, Po-Yu;
Yang, Chi-Lan;
Chen, San-Ni

Publication type:

Article

Six-month outcomes of switching from aflibercept to faricimab in refractory cases of neovascular age-related macular degeneration.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2024, v. 262, n. 1, p. 43, doi. 10.1007/s00417-023-06222-x

By:

Kataoka, Keiko;
Itagaki, Kanako;
Hashiya, Nozumu;
Wakugawa, Sorako;
Tanaka, Koji;
Nakayama, Makiko;
Yamamoto, Akiko;
Mukai, Ryo;
Honjyo, Jyunichiro;
Maruko, Ichiro;
Kawai, Moeko;
Miyara, Yasunori;
Terao, Nobuhiro;
Wakatsuki, Yu;
Onoe, Hajime;
Mori, Ryusaburo;
Koizumi, Hideki;
Sekiryu, Tetsuju;
Iida, Tomohiro;
Okada, Annabelle A.

Publication type:

Article

Predictive factors for outcomes of half-dose photodynamic therapy combined with aflibercept for pachychoroid neovasculopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 8, p. 2235, doi. 10.1007/s00417-023-06030-3

By:

Takeuchi, Jun;
Ota, Hikaru;
Nakano, Yuyako;
Horiguchi, Etsuyo;
Taki, Yosuke;
Ito, Yasuki;
Terasaki, Hiroko;
Nishiguchi, Koji M;
Kataoka, Keiko

Publication type:

Article

Simultaneous intravitreal aflibercept and gas injections for submacular hemorrhage secondary to polypoidal choroidal vasculopathy.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 6, p. 1545, doi. 10.1007/s00417-022-05922-0

By:

Wakabayashi, Taku;
Hara, Chikako;
Shiraki, Akihiko;
Shiraki, Nobuhiko;
Sayanagi, Kaori;
Sakimoto, Susumu;
Sato, Shigeru;
Sakaguchi, Hirokazu;
Nishida, Kohji

Publication type:

Article

Final 4-year results of the RAINBOW real-world study: intravitreal aflibercept dosing regimens in France in treatment-naïve patients with neovascular age-related macular degeneration.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 4, p. 959, doi. 10.1007/s00417-022-05900-6

By:

Cohen, Salomon-Yves;
Dominguez, Marcel;
Coscas, Florence;
Faure, Céline;
Baillif, Stéphanie;
Oubraham, Hassiba;
Kodjikian, Laurent;
Weber, Michel

Publication type:

Article

Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 2, p. 345, doi. 10.1007/s00417-022-05793-5

By:

Ueda-Consolvo, Tomoko;
Tanigichi, Aya;
Numata, Ayaka;
Oiwake, Toshihiko;
Nakamura, Tomoko;
Ishida, Masaaki;
Yanagisawa, Shuichiro;
Hayashi, Atsushi

Publication type:

Article

Correction to: Intravitreal aflibercept for diabetic macular edema in real‑world clinical practice in Japan: 24‑month outcomes.

Published in:

2023

By:

Sugimoto, Masahiko;
Handa, Chiharu;
Hirano, Kazufumi;
Sunaya, Toshiyuki;
Kondo, Mineo

Publication type:

Correction Notice

Comparison of 3-year outcomes of photodynamic therapy combined with intravitreal ranibizumab or aflibercept for polypoidal choroidal vasculopathy in a European cohort.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 11, p. 3533, doi. 10.1007/s00417-022-05724-4

By:

Liu, Siyin;
Chhabra, Ramandeep

Publication type:

Article

Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 11, p. 3489, doi. 10.1007/s00417-022-05703-9

By:

Sugimoto, Masahiko;
Handa, Chiharu;
Hirano, Kazufumi;
Sunaya, Toshiyuki;
Kondo, Mineo

Publication type:

Article

PERSEUS-IT 24-month analysis: a prospective observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Italy in patients with neovascular age-related macular degeneration.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 10, p. 3185, doi. 10.1007/s00417-022-05679-6

By:

Nicolò, Massimo;
Ciucci, Francesco;
Nardi, Marco;
Parolini, Barbara;
Russo, Andrea;
Scupola, Andrea;
Torregrossa, Salvatore;
Vadalà, Maria

Publication type:

Article

Brolucizumab for pre-treated patients with choroidal neovascularization and signs of tachyphylaxis to aflibercept and bevacizumab.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 8, p. 2561, doi. 10.1007/s00417-022-05634-5

By:

Boltz, Agnes;
Radunsky, Katharina;
Weingessel, Birgit;
Vécsei-Marlovits, Veronika Pia

Publication type:

Article

Outcomes after switching eyes that were stable on aflibercept to ranibizumab versus continuing aflibercept in neovascular age-related macular degeneration.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 8, p. 2509, doi. 10.1007/s00417-022-05601-0

By:

Salabati, Mirataollah;
Obeid, Anthony;
Mahmoudzadeh, Raziyeh;
Gupta, Omesh;
Chiang, Allen;
Spirn, Marc;
Klufas, Michael A.;
Hsu, Jason

Publication type:

Article

Correction to: Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study.

Published in:

2022

By:

Ohji, Masahito;
Okada, Annabelle A.;
Sasaki, Koji;
Moon, SungChul Charles;
Machewitz, Tobias;
Takahashi, Kanji

Publication type:

Correction Notice

Comparison of agents using higher dose anti-VEGF therapy for treatment-resistant neovascular age-related macular degeneration.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 7, p. 2239, doi. 10.1007/s00417-021-05547-9

By:

Broadhead, Geoffrey K.;
Keenan, Tiarnan D. L.;
Chew, Emily Y.;
Wiley, Henry E.;
Cukras, Catherine A.

Publication type:

Article

Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 4, p. 1083, doi. 10.1007/s00417-021-05359-x

By:

Quist, S. W.;
de Jong, L. A.;
van Asten, F.;
Knoester, P.;
Postma, M. J.;
Freriks, R. D.

Publication type:

Article

Changes of retinal oxygen saturation during treatment of diabetic macular edema with a pre-defined regimen of aflibercept: a prospective study.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2022, v. 260, n. 2, p. 451, doi. 10.1007/s00417-021-05319-5

By:

Hasan, Somar M.;
Hammer, Martin;
Meller, Daniel

Publication type:

Article

Intravitreal air bubbles following intravitreal injections: a comprehensive analysis.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 12, p. 3697, doi. 10.1007/s00417-021-05302-0

By:

Krauthammer, Mark;
Trabelsi, Etty;
Moisseiev, Elad

Publication type:

Article

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen: subgroup and post-hoc analyses from the ALTAIR study.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 12, p. 3637, doi. 10.1007/s00417-021-05293-y

By:

Ohji, Masahito;
Okada, Annabelle A.;
Sasaki, Koji;
Moon, SungChul Charles;
Machewitz, Tobias;
Takahashi, Kanji

Publication type:

Article

Prospective trial of treat-and-extend regimen with aflibercept for branch retinal vein occlusion: 1-year results of the PLATON trial.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 10, p. 2879, doi. 10.1007/s00417-021-05150-y

By:

Park, Dong-Geun;
Jeong, Woo Jin;
Park, Jung Min;
Kim, Jung-Yeul;
Ji, Yong-Sok;
Sagong, Min

Publication type:

Article

PERSEUS 24-month analysis: a prospective non-interventional study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in Germany in patients with neovascular age-related macular degeneration.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 8, p. 2213, doi. 10.1007/s00417-021-05073-8

By:

Eter, Nicole;
Hasanbasic, Zoran;
Keramas, Georgios;
Rech, Christine;
Sachs, Helmut;
Schilling, Harald;
Wachtlin, Joachim;
Wiedemann, Peter;
Framme, Carsten

Publication type:

Article

Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 8, p. 2085, doi. 10.1007/s00417-020-05059-y

By:

Granstam, Elisabet;
Aurell, Sandra;
Sjövall, Kersti;
Paul, Anna

Publication type:

Article

Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2021, v. 259, n. 8, p. 2181, doi. 10.1007/s00417-020-05048-1

By:

Garweg, Justus G.;
Gerhardt, Christin

Publication type:

Article

High-dose Aflibercept with Increased Dosing Intervals as a New Standard of Care for DMO and nAMD.

Published in:

touchREVIEWS in Ophthalmology, 2023, v. 17, n. 1, p. 8, doi. 10.17925/usor.2023.17.1.8

By:

Adrean, Sean

Publication type:

Article

Comparison of the effects of 3 different anti-VEGF drugs on cornea thickness, lens thickness and anterior chamber depth: Case-Control Study.

Published in:

Medicine Science, 2023, v. 12, n. 1, p. 76, doi. 10.5455/medscience.2023.01.02

By:

Eski, Mehmet Tahir;
Teberik, Kuddusi;
Sezer, Taha

Publication type:

Article

雷珠单抗与阿柏西普玻璃体腔注射治疗渗出性年龄相关性黄斑变性的疗效观察.

Published in:

Progress in Modern Biomedicine, 2019, v. 19, n. 21, p. 4129, doi. 10.13241/j.cnki.pmb.2019.21.029

By:

龚珂;
张妍春;
孙文涛;
屈超义;
雷春灵

Publication type:

Article

Anti-Vascular Endothelial Growth Factor Therapy Regimens for Polypoidal Choroidal Vasculopathy: A Systematic Review.

Published in:

Ophthalmologica, 2023, v. 246, n. 3/4, p. 245, doi. 10.1159/000533529

By:

Mihalache, Andrew;
Hatamnejad, Amin;
Patil, Nikhil S.;
Popovic, Marko M.;
Muni, Rajeev H.;
Kertes, Peter J.;
Wong, David T.

Publication type:

Article

Optical Coherence Tomography Angiography in Diabetic Macular Edema Treated with Intravitreal Aflibercept: A 48-Week Observational Study (the DOCTA Study).

Published in:

Ophthalmologica, 2023, v. 246, n. 2, p. 71, doi. 10.1159/000528426

By:

Korobelnik, Jean-François;
Gaucher, David;
Baillif, Stéphanie;
Creuzot-Garcher, Catherine;
Kodjikian, Laurent;
Weber, Michel

Publication type:

Article

Intravitreal Aflibercept versus Brolucizumab for Treatment-Naive Neovascular Age-Related Macular Degeneration with Type 1 Macular Neovascularization: Comparison of Short-Term Outcomes.

Published in:

Ophthalmologica, 2022, v. 245, n. 5, p. 413, doi. 10.1159/000526044

By:

Hoshino, Junki;
Matsumoto, Hidetaka;
Mukai, Ryo;
Nakamura, Kosuke;
Akiyama, Hideo

Publication type:

Article

Combination Therapy with N-Acetylserotonin and Aflibercept Activated the Akt/Nrf2 Pathway to Inhibit Apoptosis and Oxidative Stress in Rats with Retinal Ischemia–Reperfusion Injury.

Published in:

Current Eye Research, 2024, v. 49, n. 3, p. 280, doi. 10.1080/02713683.2023.2276059

By:

Zhang, Jing;
Zhang, Zhulin;
Jiang, Lin;
He, Shu;
Long, Xin;
Zheng, Xiao

Publication type:

Article

Simultaneous Release of Aflibercept and Dexamethasone from an Ocular Drug Delivery System.

Published in:

Current Eye Research, 2022, v. 47, n. 7, p. 1034, doi. 10.1080/02713683.2022.2053166

By:

Rudeen, Kayla M.;
Liu, Wenqiang;
Mieler, William F.;
Kang-Mieler, Jennifer J.

Publication type:

Article

FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study.

Published in:

International Journal of Cancer, 2022, v. 151, n. 11, p. 1978, doi. 10.1002/ijc.34166

By:

Torregrosa, Cécile;
Pernot, Simon;
Vaflard, Pauline;
Perret, Audrey;
Tournigand, Christophe;
Randrian, Violaine;
Doat, Solene;
Neuzillet, Cindy;
Moulin, Valérie;
Stouvenot, Morgane;
Roth, Gael;
Darbas, Tiffany;
Auberger, Benjamin;
Godet, Tiphaine;
Jaffrelot, Marion;
Lambert, Aurélien;
Dubreuil, Olivier;
Gluszak, Cassandre;
Bernard‐Tessier, Alice;
Turpin, Anthony

Publication type:

Article

Successful delivery of subretinal aflibercept (new surgical technique) for the treatment of submacular hemorrhage in idiopathic polypoidal choroidal vasculopathy.

Published in:

2021

By:

Chalam, K V;
Gasparian, Suzie

Publication type:

Case Study

Combined therapy with intravitreal aflibercept and subtenon corticosteroids in eyes with severe diabetic papillopathy: two case reports.

Published in:

2021

By:

Arapi, Ilir;
Neri, Piergiorgio;
Giovannini, Alfonso;
Grezda, Arjeta

Publication type:

journal article

Real-world visual acuity outcomes for patients with naïve neovascular age-related macular degeneration treated with aflibercept, ranibizumab, or bevacizumab in the Republic of Korea.

Published in:

PLoS ONE, 2024, v. 19, n. 10, p. 1, doi. 10.1371/journal.pone.0310381

By:

Lee, Yeo Jin;
Kang, Seungbum;
Won, Jae Yon;
Roh, Young Jung;
Ra, Ho;
Lee, Mee yon;
Park, Sung Pyo;
Jee, Dong Hyun

Publication type:

Article

Effects of aflibercept and bevacizumab on cell viability, cell metabolism and inflammation in hypoxic human Müller cells.

Published in:

PLoS ONE, 2024, v. 19, n. 3, p. 1, doi. 10.1371/journal.pone.0300370

By:

Matsuda, Monique;
da Silva, Rafael André;
Roda, Vinicius Moraes de Paiva;
Marquezini, Mônica Valéria;
Monteiro, Mário Luiz Ribeiro;
Hamassaki, Dânia Emi

Publication type:

Article

Aflibercept Off-Target Effects in Diabetic Macular Edema: An In Silico Modeling Approach.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3621, doi. 10.3390/ijms25073621

By:

Blanot, Morgane;
Casaroli-Marano, Ricardo Pedro;
Mondéjar-Medrano, Jordi;
Sallén, Thaïs;
Ramírez, Esther;
Segú-Vergés, Cristina;
Artigas, Laura

Publication type:

Article

Herniation of orbital fat -- analysis of the surgical repair.

Published in:

Ophthalmology Journal (2450-7873), 2021, p. 161, doi. 10.5603/OJ.2021.0029

By:

Tzivaridou, Despoina;
Marini, Christina;
Mallias, Ioannis

Publication type:

Article

Comparison of the efficiency of subconjunctival aflibercept ranibizumab and bevacizumab in corneal neovascularization in a rat model.

Published in:

Ophthalmology Journal (2450-7873), 2021, p. 155, doi. 10.5603/OJ.2021.0026

By:

Kocamış, Sücattin İlker;
Can, Mehmet Erol;
Şimşek, Gülçin Güler;
Çakmak, Hasan Basri

Publication type:

Article

Patolojik Miyopiye Sekonder Koroidal Neovaskülarizasyon Olgularında Farklı Anti-VEGF Ajanların Etkinliğinin Karşılaştırılması: 4 Yıllık Gerçek Yaşam Verileri.

Published in:

MN Opthalmology / MN Oftalmoloji, 2024, v. 31, n. 4, p. 190

By:

ÖZBEK, Merve;
ÖZÇALIŞKAN, Şehnaz;
ARTUNAY, Özgür

Publication type:

Article

Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma.

Published in:

Siriraj Medical Journal, 2022, v. 74, n. 1, p. 27, doi. 10.33192/Smj.2022.4

By:

Kitnarong, Naris;
Kittipiriyakul, Janyawassamon;
Jiravarnsirikul, Anuwat

Publication type:

Article

Clinical Characteristics of Punctate Hyperfluorescence Spots in the Fellow Eye of Patients with Unilateral Macular Neovascularization with No Drusen.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 18, p. 5394, doi. 10.3390/jcm13185394

By:

Kamao, Hiroyuki;
Goto, Katsutoshi;
Date, Yuto;
Hiraki, Ryutaro;
Mizukawa, Kenichi;
Miki, Atsushi

Publication type:

Article

Inflammation and Vasculitis Related to Brolucizumab.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 17, p. 5208, doi. 10.3390/jcm13175208

By:

Campos, António;
Mota, Carolina;
Caramelo, Francisco;
Oliveira, Nuno;
Silva, Sara;
Sousa, João

Publication type:

Article

Switching to Intravitreal Brolucizumab after Ranibizumab or Aflibercept Using Treat and Extend Regimen for Neovascular Age-Related Macular Degeneration in Japanese Patients: 1-Year Results and Factors Associated with Treatment Responsiveness.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4375, doi. 10.3390/jcm13154375

By:

Hirayama, Kumiko;
Yamamoto, Manabu;
Honda, Shigeru;
Kyo, Akika;
Misawa, Norihiko;
Kohno, Takeya

Publication type:

Article